We are live on
!
Find out more
RCM
Raleigh Capital Management Portfolio holdings
AUM
$313M
1-Year Est. Return
23.55%
This Fund
S&P 500
This Quarter
Est. Return
+1.31%
1 Year Est. Return
+23.55%
3 Year Est. Return
+71.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$202M
AUM Growth
+$9.92M
(+5.2%)
Cap. Flow
+$9.69M
Cap. Flow
% of AUM
4.79%
Top 10 Holdings %
Top 10 Hldgs %
19.02%
Holding
917
New
150
Increased
411
Reduced
129
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$2.07M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.01M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48M |
| 4 |
Entergy
ETR
|
+$1.18M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$1.98M |
| 2 |
Vodafone
VOD
|
+$1.64M |
| 3 |
Gilead Sciences
GILD
|
+$1.59M |
| 4 |
JPMorgan Chase
JPM
|
+$1.48M |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.57% |
| 2 | Consumer Staples | 9.48% |
| 3 | Financials | 8.63% |
| 4 | Utilities | 7.49% |
| 5 | Energy | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Neurocrine Biosciences
NBIX
$16.6B
| $6.68K | ﹤0.01% |
66
+29
| +78% | +$3.02K |
|
|
CYBR
577
DELISTED
CyberArk
CYBR
| $6.66K | ﹤0.01% |
45
| – | – |
|
578
Regeneron Pharmaceuticals
REGN
$80.8B
| $6.57K | ﹤0.01% |
+8
| New | +$6.03K |
|
579
Array Technologies
ARRY
$855M
| $6.3K | ﹤0.01% |
288
+125
| +77% | +$2.56K |
|
580
Cencora
COR
$61.2B
| $6.26K | ﹤0.01% |
+39
| New | +$6.19K |
|
581
GATX Corp
GATX
$6.27B
| $6.21K | ﹤0.01% |
56
+6
| +12% | +$654 |
|
582
iShares S&P 100 ETF
OEF
$20.5B
| $6.2K | ﹤0.01% |
33
| – | – |
|
583
Warner Bros
WBD
$67.1B
| $6.13K | ﹤0.01% |
406
+4
| +1% | +$57 |
|
|
SWAV
584
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.07K | ﹤0.01% |
28
+6
| +27% | +$1.17K |
|
585
Allstate
ALL
$67.5B
| $6.02K | ﹤0.01% |
54
-1,694
| -97% | -$214K |
|
586
Vertex Pharmaceuticals
VRTX
$126B
| $5.99K | ﹤0.01% |
+19
| New | +$5.7K |
|
587
Lindsay Corp
LNN
$1.18B
| $5.91K | ﹤0.01% |
39
+6
| +18% | +$907 |
|
588
Matador Resources
MTDR
$6.09B
| $5.88K | ﹤0.01% |
123
+21
| +21% | +$1.18K |
|
589
Veeva Systems
VEEV
$37.4B
| $5.88K | ﹤0.01% |
+32
| New | +$5.46K |
|
590
PagerDuty
PD
$902M
| $5.84K | ﹤0.01% |
167
+21
| +14% | +$617 |
|
591
State Street SPDR S&P Homebuilders ETF
XHB
$1.62B
| $5.8K | ﹤0.01% |
86
-108
| -56% | -$7.21K |
|
|
EQC
592
DELISTED
Equity Commonwealth
EQC
| $5.71K | ﹤0.01% |
276
+70
| +34% | +$1.62K |
|
593
Cal-Maine
CALM
$3.99B
| $5.64K | ﹤0.01% |
93
+32
| +52% | +$1.78K |
|
594
City Holding Co
CHCO
$2.04B
| $5.59K | ﹤0.01% |
62
+10
| +19% | +$946 |
|
595
Watts Water Technologies
WTS
$13.1B
| $5.57K | ﹤0.01% |
33
+6
| +22% | +$989 |
|
596
Zimmer Biomet
ZBH
$18.4B
| $5.56K | ﹤0.01% |
+43
| New | +$5.4K |
|
597
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.2B
| $5.55K | ﹤0.01% |
194
+19
| +11% | +$601 |
|
598
Brown-Forman Class B
BF.B
$13.1B
| $5.54K | ﹤0.01% |
86
| – | – |
|
599
Organon & Co
OGN
$3.57B
| $5.43K | ﹤0.01% |
+231
| New | +$6.2K |
|
600
Murphy USA
MUSA
$9.61B
| $5.43K | ﹤0.01% |
21
+1
| +5% | +$260 |
|
Similar funds
WMIG
JIC
MIM
SL
TF
WIC
CFLC
NTCM
Raleigh Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Raleigh Capital Management held 917 positions worth $202M, up 5.2% from $192M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Raleigh Capital Management deployed $9.69M of net new capital in Q1 2023, opening 150 new positions and adding to 411 existing holdings. Its largest new stake was iShares MSCI USA Quality Factor ETF: 17,260 shares worth $2.14M.
By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, down from 10% a quarter earlier, followed by Consumer Staples and Financials.
On the sell side, the largest reduction was iShares ESG Aware MSCI USA ETF, an estimated $1.98M trimmed.
- Raleigh Capital Management's largest Q1 2023 buy was iShares MSCI USA Quality Factor ETF: 17,260 shares worth $2.14M.
- Raleigh Capital Management added most to Invesco QQQ Trust in Q1 2023, an estimated $2.01M increase.
- Raleigh Capital Management's biggest Q1 2023 reduction was iShares ESG Aware MSCI USA ETF, cutting an estimated $1.98M.
- Raleigh Capital Management fully exited iShares Floating Rate Bond ETF in Q1 2023, selling an estimated $462K.
- Raleigh Capital Management's ten largest holdings make up 19% of its $202M portfolio in Q1 2023.
- Raleigh Capital Management opened 150 new positions and closed 76 in Q1 2023.
- Raleigh Capital Management's portfolio value rose 5.2% quarter-over-quarter to $202M.
Based on Raleigh Capital Management's 13F filing for Q1 2023, filed 22 May 2023.